Molecular clues into the pathogenesis of statin‐mediated muscle toxicity
- 14 February 2005
- journal article
- review article
- Published by Wiley in Muscle & Nerve
- Vol. 31 (5), 572-580
- https://doi.org/10.1002/mus.20291
Abstract
The pathophysiology of statin‐mediated muscle dysfunction is poorly defined. Reductions in skeletal muscle membrane cholesterol were initially thought to account for the range of myopathic reactions, e.g., myalgia, elevated serum creatine kinase, or rhabdomyolysis. This assumption however, does not consider a potential role of the isoprenoids in the pathophysiology of statin myopathy. The observation that derangements in mevalonate kinase (MK), but not more distal enzymes of cholesterologenesis, are associated with a skeletal myopathy suggests a critical role for the isoprenoids in the maintenance of muscle. Statins also deplete the isoprenoid pool by inhibiting the enzyme, β‐hydroxy‐β‐methylglutaryl coenzyme A reductase, which is upstream of MK. Identifying candidate proteins that are both dependent on isoprenoid‐mediated modification and associated with muscle disease, when genetically mutated, offers further insight into potential mechanisms of statin myopathy. For example, lamin A/C, selenoprotein N, α‐ and β‐dystroglycan, and cytoskeletal G‐proteins all require isoprenylation for optimal function. Understanding the pleiotropic effects of protein prenylation, and the potential consequences of a generalized insufficiency of this form of protein modification, may help clarify the molecular pathogenesis of statin myopathy. Muscle Nerve, 2005Keywords
This publication has 84 references indexed in Scilit:
- Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophiesNature, 2002
- Role of tyrosine phosphorylation of phospholipase C γ1 in the signaling pathway of HMG‐CoA reductase inhibitor‐induced cell death of L6 myoblastsFEBS Letters, 1999
- Mitochondrial abnormalities in selenium-deficient myopathyMuscle & Nerve, 1998
- HMG CoA Reductase Inhibitor-Induced Myotoxicity: Pravastatin and Lovastatin Inhibit the Geranylgeranylation of Low-Molecular-Weight Proteins in Neonatal Rat Muscle Cell CultureToxicology and Applied Pharmacology, 1997
- The effect of Simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscleThe American Journal of Cardiology, 1996
- Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled StudyThe Journal of Clinical Pharmacology, 1993
- The functional role of the β‐subunit in the maturation and intracellular transport of Na,K‐ATPaseFEBS Letters, 1991
- Colchicine Myopathy and NeuropathyNew England Journal of Medicine, 1987
- N6-(Δ2-isopentenyl)adenosine: Biosynthesis in vitro in transfer RNA by an enzyme purified from escherichia coliBiochemical and Biophysical Research Communications, 1970